Uncategorized
The Role of Polo-Like Kinase 1 (PLK1) in Non-Small Cell Lung Cancer: Molecular Mechanisms and Therapeutic Implications
[Biochemical Pharmacology] The authors evaluate the molecular mechanisms by which Polo-like kinase 1 (PLK1) drives NSCLC pathogenesis, including its regulation by transcription factors, tumor suppressors, oncogenes, non-coding RNAs, and signaling pathways.
U. Professor Leads Team Awarded $6.5 Million Grant to Create Lung Cancer Simulation Models
[The Daily Targum ] Researchers were recently awarded a five-year, $6.5 million grant by the National Cancer Institute to fund advanced simulation models to estimate future health issues associated with lung cancer and tobacco use.
NKCC1 in Sepsis-Related Acute Lung Injury: Emerging Links to Macrophage-Neutrophil Crosstalk
[European Journal of Pharmacology] Scientists evaluate studies examining macrophages, neutrophils, and sodium-potassium-chloride cotransporter 1 (NKCC1) in acute lung injury, focusing on NKCC1 and its interactions with macrophages and neutrophils.
A Single-Cell Lung Cancer Atlas Reveals Cellular and Molecular Drivers of Metastasis and Clinical Outcome
[Nature Cancer] Researchers present LuCaS+, a multicenter single-cell RNA sequencing atlas comprising over 2.5 million nuclei from 454 clinically annotated patients with NSCLC with long-term follow-up.
Deptor Deficiency Protects against Acute Lung Injury through Autophagy Regulation
[Scientific Reports] Investigators used type II alveolar epithelial cell-specific Deptor knockout mice subjected to hemorrhagic shock and intratracheal lipopolysaccharide instillation as an in vivo model, and employed LPS-stimulated MLE-12 cells for in vitro mechanistic exploration.
Selective Inhibition of EGFR-Mutant Lung Cancer Cell Proliferation by CRISPR/Cas9 Targeting
[Molecular Therapy Oncology] The authors developed a CRISPR/Cas9-based therapy targeting the EGFR exon 19 deletion mutation. Mechanistically, CRISPR-edited cells exhibited decreased EGFR-AKT signaling activity, reduced cell division, G1/G0 phase arrest, and increased apoptosis.
RNA Sequencing Reveals Molecular Subtypes across Adenocarcinoma, Squamous, and Small Cell Lung Cancer
[Cell Genomics] Scientists combined RNA sequencing data from 1,824 tumors across major lung cancer types to examine how tumor gene expression patterns relate to histologic diagnoses.
Transcriptional Analyses of Patient Derived Xenograft Models Reveal Distinct Subsets of Small Cell Lung Cancer
[Cell Reports] Reseachers applied non-negative matrix factorization to gene expression data from 146 SCLC patient-derived xenograft models. They identified three ASCL1-dominant and three NEUROD1-dominant subsets, an ASCL1/NEUROD1 co-active subset, and a REST-active low-neuroendocrine subset.
Low-Solvent Mechanochemical MOF Carrier Nanoarchitectonics for Targeted Quercetin Delivery for Dual-Mode ROS and Anti-Inflammation Protection against LPS-Induced Acute Lung Injury
[ACS Applied Materials & Interfaces] Scientists reported a low-solvent mechanochemical synthesis method to formulate cerium-doped zeolitic imidazolate frameworks stabilized by Pluronic F127 as drug delivery nanocarriers to load quercetin for targeted preventive acute lung injury therapy.
Noradrenergic Input from Sympathetic Nerves to Fibroblasts Regulates Lung Fibrosis
[Science Translational Medicine] Researchers showed that a fibrogenic unit comprising sympathetic nerve–derived noradrenaline and α1-adrenoreceptor subtype D-positive effector fibroblasts promotes lung fibrosis in disease-relevant modeling systems.
NRF2 Is a Mechanosensitive Checkpoint for NLRP3 Inflammasome Activation
[Nature] Researchers reported that ECM stiffness is a determinant of NLRP3 activities and that in vitro systems using physiological ECM stiffness enable one-signal in vivo-like NLRP3 activities to occur in human and mouse phagocytes.
Disassembly of Extracellular Matrix and Intercellular Adhesion Enables Noninvasive Bladder Cancer Disaggregation
[ACS Nano] Scientists constructed a layered double hydroxide nanoplatform coloaded with collagenase and EDTA. The nanosystem efficiently degrades key ECM components, thereby relieving steric hindrance and exposing cellular surfaces.

Cancer Stem Cell News
Cell Therapy News
Dermal Cell News
Endothelial Cell News
ESC & iPSC News
Extracellular Matrix News
Hematopoiesis News
Hepatic Cell News
Human Immunology News
Immune Regulation News
Intestinal Cell News
Mammary Cell News
Mesenchymal Cell News
Muscle Cell News
Neural Cell News
Organoid News
Pancreatic Cell News
Prostate Cell News
Pulmonary Cell News
